See more : Plutonian Acquisition Corp. (PLTN) Income Statement Analysis – Financial Results
Complete financial analysis of Nova Leap Health Corp. (NVLPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nova Leap Health Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Lemon Tree Hotels Limited (LEMONTREE.NS) Income Statement Analysis – Financial Results
- Mallard Acquisition Corp. (MACUU) Income Statement Analysis – Financial Results
- CGN Power Co., Ltd. (1816.HK) Income Statement Analysis – Financial Results
- Wolverine Energy and Infrastructure Inc. (WEII.V) Income Statement Analysis – Financial Results
- Saab AB (publ) (SAAB-B.ST) Income Statement Analysis – Financial Results
Nova Leap Health Corp. (NVLPF)
About Nova Leap Health Corp.
Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders by nursing staff. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.18M | 28.21M | 21.28M | 17.31M | 17.40M | 10.36M | 1.06M | 39.99K |
| Cost of Revenue | 16.41M | 18.23M | 14.07M | 11.44M | 11.56M | 7.04M | 693.95K | 24.55K |
| Gross Profit | 9.77M | 9.98M | 7.21M | 5.87M | 5.84M | 3.32M | 365.90K | 15.44K |
| Gross Profit Ratio | 37.31% | 35.37% | 33.89% | 33.92% | 33.58% | 32.04% | 34.52% | 38.61% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.42M | 9.68M | 7.58M | 5.72M | 5.34M | 3.64M | 1.18M | 440.11K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.04K | 1.73K |
| SG&A | 8.42M | 9.68M | 7.58M | 5.72M | 5.34M | 3.64M | 1.19M | 441.83K |
| Other Expenses | 885.11K | -37.42K | -25.84K | 0.00 | 0.00 | 0.00 | 0.00 | -35.74K |
| Operating Expenses | 9.31M | 11.04M | 3.32M | 4.06M | 5.96M | 4.08M | 1.23M | 481.25K |
| Cost & Expenses | 25.72M | 29.27M | 17.39M | 15.49M | 17.52M | 11.13M | 1.92M | 505.80K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.13K | 895.00 |
| Interest Expense | 147.40K | 270.99K | 401.12K | 448.12K | 460.73K | 312.92K | 21.84K | 3.23K |
| Depreciation & Amortization | 534.31K | 1.30M | 853.88K | 572.97K | 633.05K | 420.15K | 36.87K | 3.20K |
| EBITDA | 994.47K | 256.39K | 3.74M | 1.12M | 128.29K | -284.94K | -899.66K | -504.95K |
| EBITDA Ratio | 3.80% | 0.91% | 22.35% | 13.63% | 2.91% | -3.10% | -77.44% | -1,154.43% |
| Operating Income | 460.15K | -1.06M | -1.23M | -396.08K | -112.83K | 763.74K | -907.15K | -515.24K |
| Operating Income Ratio | 1.76% | -3.77% | -5.79% | -2.29% | -0.65% | 7.37% | -85.59% | -1,288.39% |
| Total Other Income/Expenses | -1.83M | -144.45K | 3.70M | 521.63K | -838.28K | -276.85K | -18.71K | -35.74K |
| Income Before Tax | -1.37M | -1.21M | 2.47M | 125.52K | -951.11K | -1.04M | -925.86K | -517.58K |
| Income Before Tax Ratio | -5.22% | -4.28% | 11.62% | 0.73% | -5.46% | -10.04% | -87.36% | -1,294.23% |
| Income Tax Expense | -317.02K | -370.82K | 712.52K | -1.13M | 104.70K | -79.32K | -74.25K | -28.06K |
| Net Income | -1.05M | -835.75K | 1.76M | 1.26M | -1.06M | -961.27K | -851.61K | -489.52K |
| Net Income Ratio | -4.03% | -2.96% | 8.27% | 7.26% | -6.07% | -9.28% | -80.35% | -1,224.07% |
| EPS | -0.01 | -0.01 | 0.02 | 0.02 | -0.02 | -0.02 | -0.04 | -0.04 |
| EPS Diluted | -0.01 | -0.01 | 0.02 | 0.02 | -0.02 | -0.02 | -0.04 | -0.04 |
| Weighted Avg Shares Out | 86.22M | 81.46M | 74.40M | 65.12M | 60.85M | 48.45M | 20.64M | 11.02M |
| Weighted Avg Shares Out (Dil) | 86.21M | 81.46M | 77.65M | 66.43M | 60.85M | 48.45M | 20.64M | 11.02M |
Nova Leap Health Corp. Provides Guidance of Record Adjusted EBITDA for Q2 2023 and Change of CFO
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 02, 2023 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization,...
Nova Leap Health Corp. to Present at the MicroCap Rodeo Winter Wonderland Virtual Investor Conference
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. Grants Deferred Share Units
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. places No. 42 on The Globe and Mail's third-annual ranking of Canada's Top Growing Companies
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. Announces Participation at the Lytham Partners Fall 2021 Investor Conference
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. Completes Purchase of Oklahoma Home Care Business
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
President & CEO of Nova Leap Health Corp. to Present at the Q3 Virtual Investor Summit
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. Posts Record Revenues for Second Quarter 2021
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. Completes Purchase of New England Home Care Business
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Nova Leap Health Corp. to Force Conversion of 8% Convertible Debentures due January 16, 2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Source: https://incomestatements.info
Category: Stock Reports